Mirae Asset Global Investments’s Inhibrx INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$62.2K Sell
656
-103
-14% -$10.3K ﹤0.01% 1328
2026
Q1
$51K Buy
759
+52
+7% +$3.86K ﹤0.01% 1292
2025
Q4
$55.9K Buy
707
+147
+26% +$10K ﹤0.01% 1371
2025
Q3
$18.9K Buy
560
+1
+0.2% +$25 ﹤0.01% 1505
2025
Q2
$7.98K Buy
559
+71
+15% +$918 ﹤0.01% 1514
2025
Q1
$6.89K Buy
488
+6
+1% +$81 ﹤0.01% 1500
2024
Q4
$7.24K Buy
+482
New +$7.34K ﹤0.01% 1536

Other funds holding INBX

Mirae Asset Global Investments's INBX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Inhibrx (INBX) stake by 14% in Q2 2026, selling an estimated $10.3K and leaving 656 shares worth $62.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1328.

Mirae Asset Global Investments first reported a position in INBX in Q4 2024 and has held it in 7 quarters since. 46 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Mirae Asset Global Investments held 656 shares of Inhibrx worth $62.2K as of Q2 2026.
  • Mirae Asset Global Investments sold 103 Inhibrx shares in Q2 2026, an estimated $10.3K.
  • Inhibrx made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1328 holding.
  • Mirae Asset Global Investments first reported a position in Inhibrx in Q4 2024 and has held it in 7 quarters since.
  • 46 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.